Ric Kayne Issues Letter To Athira Shareholders Highlighting Need For Immediate Change To Athira Board
Dear Fellow Athira Shareholders,
Athira Pharma, Inc.’s (NASDAQ: ATHA) (“Athira” or the “Company”) May 19th annual meeting is just over a week away and time is running out to vote to elect directors—myself and George Bickerstaff—WHO WILL ACT IN YOUR BEST INTERESTS AND PROTECT THE VALUE OF YOUR INVESTMENT.
The endless string of poor decisions by Athira’s Bo…